NCT01818583View on ClinicalTrials.gov

Potassium Infusion for Conversion of Atrial Fibrillation/-Flutter

PHASE4CompletedINTERVENTIONAL
Enrollment

143

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Atrial FibrillationAtrial Flutter
Interventions
DRUG

Potassium chloride

DRUG

Glucose 50 MG/ML

Trial Locations (1)

0370

Diakonhjemmet Hospital, Oslo

All Listed Sponsors
lead

Diakonhjemmet Hospital

OTHER

NCT01818583 - Potassium Infusion for Conversion of Atrial Fibrillation/-Flutter | Biotech Hunter | Biotech Hunter